Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2005

View Archived Issues

New phase IIb study for CS-917 in type 2 diabetes

Japanese phase II study of BAY-43-9006 for advanced renal cell carcinoma

Valeant submits complete response for Zelapar

PA-457 awarded fast track status for HIV

Fast track designation for epratuzumab in lupus

Approvable letter for Bonefos for adjuvant treatment of breast cancer

Sirna launches programs to treat asthma and diabetes with RNAi technology

VX-680 enters phase I study in solid tumor patients

IND submission for HCV-796

Peplin reports positive phase I results for PEP-005 Topical

Priority review for Aceon sNDA

New phase III trial evaluates Velcade in newly diagnosed multiple myeloma

Dosing completed in phase II study of Puricase for severe gout

Human Genome Sciences cleared for phase I study of CCR5 mAb for HIV

Sangamo submits IND for SB-509 to treat diabetic neuropathy

Treatment phase begins in SHEPHERD study of eculizumab for PNH

gamma-Tocopherol, a vitamin E form, is effective against prostate cancer

Therapeutic vaccine protects against HIV-induced autoimmunity

HCV NS3-NS4A protease inhibitor and INF-alpha synergistically inhibit HCV replication in vitro

Azithromycin improves coronary microcirculation in CAD patients

Low menaquinone levels related to coronary heart disease

Thiazolidinedione derivatives claimed by Incyte

Ono discloses a series of CCR5 receptor antagonists

Akt inhibitors prepared and tested at Lilly

Kalypsys patent covers novel PPAR modulators for obesity, diabetes, etc.

Tachykinin NK2 antagonists in early development at Menarini

Scientists at Enanta report novel agents for hepatitis C infections

Muscarinic M1 receptor antagonists emerge from research at Lilly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...